François Ghiringhelli

5 ta ish

French Institute of Health and Medical Research

1. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

   Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

   Maqola20175 iqtibos

   ABIABI:AkademIndex/2026.other.339917

2. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

   Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas +40

   Maqola20223 iqtibos

   ABIABI:AkademIndex/2026.other.480530

3. Transport, stability, and biological activity of resveratrol

   Dominique Delmas, Virginie Aires, Emeric Limagne +4

   Sharh maqola20112 iqtibos

   ABIABI:AkademIndex/2026.other.267431

4. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

   Mélanie Bruchard, Grégoire Mignot, Valentin Dérangère +12

   Maqola20122 iqtibos

   ABIABI:AkademIndex/2026.other.276360

5. The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

   Sophie Viaud, Fabiana Saccheri, Grégoire Mignot +30

   Maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.339861